STERIS AST offers medical device product testing capabilities to support our global expansions 

November 10, 2020

STERIS Applied Sterilization Technologies (AST) continues to expand its capacity for routine sterilization of medical devices, including new X-ray facilities in a number of locations worldwide.

In addition, STERIS is adding new specialized Radiation Technology Centers in the UK and North America.

Our STERIS laboratory testing services are integral in supporting these new facilities by providing medical device manufacturers with a comprehensive suite of microbiological and analytical testing and validation services to support registration of medical devices.

These tests include:

  • Full-service testing to support ISO 11137 - Dose Setting and Audits (VDmax and Method 1)
  • Full-service testing to support ISO 11135 (EO residual, Biological Indicator, Bioburden and Sterility Testing)
  • LAL testing for product release
  • Bioburden and environmental monitoring of routine production
  • Packaging testing validation support (ISO 11607)
  • Product testing including LUER Testing (ISO 80369-7)
  • Design verification and technical services for products

The increased complexity of medical devices is supported by an evolving sterilization services offering, including technologies such as X-ray and vaporized hydrogen peroxide (VHP).

By combining our global network of technology-neutral sterilization facilities, laboratory testing capabilities, and the technical knowledge of our TechTeam® professionals, STERIS AST supports Customers through new product registrations and technology transfers.

2020.01.08-Radiation-Sterilization-Validation-200px

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.
STERIS is pleased to announce our brooklyn park mn usa laboratory iso 17025 accreditation now incl
November 21, 2024
November 21, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory ISO 17025 accreditation now includes product and package testing services.